Biomining Companies: Who’s Extracting Metal With Bacteria at Scale

Microorganisms are quietly responsible for a substantial slice of the copper in the device you are reading this on. Bacteria, not blast furnaces, extract a meaningful share of the world’s copper supply, yet most people who own a copper-dependent phone or laptop have never heard the word for it.

The word is biomining, and it is having a moment. Declining ore grades, surging demand for battery metals, and tighter emissions rules are all pushing miners toward a processing method that was once considered a niche curiosity.

This is not a fringe experiment being trialled in a laboratory. It is a structural shift in how the mining industry gets metal out of rock, and the economics are moving in its favour.

What follows here maps who is actually doing this commercially, from the biggest miners on earth to venture-backed specialists, how the underlying technology works, and where its genuine limits sit. You will finish with a calibrated, non-promotional view of the sector and a framework for judging the claims you encounter.

What biomining actually does, and why it is commercially viable now

Picture a vast stacked pile of crushed low-grade ore, irrigated from above with an acidic solution teeming with bacteria. The microbes go to work on the sulfide minerals, breaking them down and releasing the metals trapped inside into the liquid that trickles through and is collected below for downstream recovery. That is bioleaching, the dominant technique within biomining, and it has been running commercially since the 1980s.

There are two main operating formats, and each suits a different situation.

Thermophilic and acidophilic bacteria, the microbes that thrive in hot and acidic conditions, do most of the heavy lifting.

The bioleaching process mechanics, from the electrochemical reactions at the mineral surface to the downstream solvent extraction and electrowinning steps that produce cathode copper, are worth understanding in detail before evaluating any project claim that references the technology.

Here is why the economics are turning. As the richest ore bodies get depleted, average grades keep falling, and lower-cost processing becomes competitive against conventional smelting that was designed for richer material. The energy transition is compounding this, because the copper, cobalt, nickel, and lithium needed for electrification are exactly the metals bioleaching can help recover.

Four forces are driving adoption right now:

• Declining ore grades across major copper and gold deposits, making cheaper processing methods viable
• Energy transition demand for battery and grid metals
• Emissions regulation targeting sulfur dioxide output from smelters
• ESG commitments, since bioleaching produces fewer toxic byproducts and uses fewer heavy chemicals

The numbers confirm this is a mature industrial process, not a pilot. Bioleaching accounts for an estimated 20% to 25% of global copper production when combined with acid-based heap leaching. The global biomining market was valued at USD 11 billion in 2024 and is projected to reach USD 27.3 billion by 2032, a compound annual growth rate of 12.33%. Bioleaching itself represents roughly 42.5% to 46% of total biomining technique revenue, with copper the leading metal at a 41% to 47.8% revenue share.

The global biomining market research from Credence Research places the sector’s 2024 valuation at USD 11 billion, with bioleaching commanding a 46% technique share and copper accounting for the largest metal segment, figures that reflect decades of accumulated industrial deployment rather than speculative projections.

That is what makes the company landscape worth understanding: the technology already works at scale.

The majors: how large mining companies embedded bioleaching into standard operations

The most persuasive evidence that biomining is real is not a startup pitch deck. It is the fact that the world’s largest copper producers have been running bioleaching operations for decades, treating it as standard practice rather than an experiment.

BHP deploys bioleaching at Escondida in Chile, one of the largest copper mines on the planet. Freeport-McMoRan uses it to process low-grade stockpile material at its American copper operations, extracting value from ore that would otherwise sit idle.

Codelco, the Chilean state-owned copper producer, applies bioleaching to extend the productive life of lower-grade ore bodies. Glencore has taken the technology into Africa, using it on cobalt and copper concentrates.

Gold miners use a closely related process called biooxidation, which is a pretreatment step rather than full bioleaching. Barrick Gold and Newmont both use it to prepare refractory gold ores, meaning ores that resist standard extraction, ahead of cyanide leaching so that more gold can be recovered.

This tier gives you a credibility baseline. When a smaller company claims a bioleaching capability, the question is whether its evidence matches the standard these operators have already set. It also explains why a licensing market for proprietary bioleaching processes exists at all.

Specialist technology developers and the companies pushing the frontier

Below the majors sits a layer of companies whose proprietary processes and named commercial projects define where the technology is actually heading. Each one is solving a specific, named problem, and those distinctions are what matter when you assess them.

Licensed process developers: BIOX, GeoBiotics, and Mintek

Biomin Technologies, a subsidiary of Gold Fields, developed the BIOX process, the most widely licensed biooxidation system for refractory gold pretreatment. BIOX has been deployed at more than ten commercial operations across Africa, South America, and Asia, which makes it the closest thing the sector has to an industry standard.

GeoBiotics developed the GEOCOAT and GEOLEACH processes, which coat coarse ore and concentrate onto support rock so bioleaching can be applied more efficiently. Mintek, South Africa’s state-owned mineral research organisation, provides much of the research and pilot-scale development that underpins commercial deployments globally.

Together, these three form the licensing and research infrastructure that lets other miners adopt bioleaching without building the science from scratch.

Rio Tinto Nuton represents a notable omission from most biomining company lists: a purpose-built venture within one of the world’s largest diversified miners, deploying a proprietary copper bioleaching platform across both internal projects and third-party licensing partnerships.

Project-stage and venture-backed companies: Jetti and BacTech

Jetti Resources is tackling the single most consequential technical gap in the sector: the difficulty of bioleaching chalcopyrite, the primary copper sulfide that conventional bioleaching cannot process efficiently. Its catalytic approach aims to break through that barrier, and the company has raised a cumulative USD 168 million to USD 192 million, with its latest major round a Series D in 2022.

The most telling detail about Jetti is who backs it.

Jetti’s investor syndicate BHP Ventures, Freeport-McMoRan, Teck Resources, Mitsubishi Corporation, and T. Rowe Price are all backers. When operating mining majors put capital into a technology, they are betting it solves a problem they cannot solve themselves.

BacTech Environmental Corporation targets a different problem: arsenic-bearing gold concentrates and tailings remediation. Its flagship Ecuador Direct project is a 50-tonnes-per-day Phase 1 plant in Ecuador targeting arsenic-rich gold concentrates, requiring roughly USD 22 million in capital expenditure and designed to produce about 35,000 ounces of gold annually while stabilising contaminants. The project received ESIA approval in 2022, and BacTech announced construction of the owner-operated facility in October 2025, with first production expected within roughly two years of the late-2024 reference point.

BacTech is also developing a Zero-Tailings program in Sudbury, Canada, an example of the waste valorisation application, recovering critical minerals from material already dug up.

Here is the specialist layer at a glance:

• BIOX (Biomin Technologies): most-licensed biooxidation system, refractory gold, over ten operations
• GeoBiotics: GEOCOAT and GEOLEACH for coarse ore and concentrate
• Mintek: research and pilot-scale process development
• Jetti Resources: catalytic bioleaching of chalcopyrite, private, majors-backed
• BacTech Environmental: arsenic-rich concentrates and tailings, Canadian and OTC listed

BacTech trades on Canadian and OTC exchanges, not the ASX, and Jetti remains private. Neither is Australian-listed, a point worth holding as we turn to the local angle.

ASX-listed companies and the Australian angle on bioleaching

If you invest through the ASX, the honest picture is that Australian-listed operators sit at an earlier stage on biomining than their global peers. That is neither a dismissal nor a reason to inflate the local story.

Austral Resources has explored bioleaching as a processing approach for its copper projects in Queensland, though this was exploratory rather than an operational deployment.

Several ASX-listed junior explorers with refractory gold and complex sulfide projects have referenced bioleaching as a potential processing pathway in their project studies. Most, however, remain at prefeasibility or earlier evaluation stages.

The important structural point is that ASX-listed miners do not need to invent the technology. They can license established bioprocessing systems such as BIOX, which lowers the entry barrier considerably and means Australian projects are not shut out of the technology.

Australia also contributes on the research side.

• Austral Resources: explored bioleaching for Queensland copper projects
• CSIRO: active research into thermophilic and extremophilic microorganisms for bioleaching
• ASX juniors: realistic access via licensing established systems such as BIOX

It is worth being direct: no ASX-listed company announcements explicitly confirming new bioleaching or biooxidation deployments at mineral projects were identified for the 2024 to 2026 period. Globally relevant players like Jetti and BacTech, though not ASX-listed, still matter to Australian mining circles and to the kinds of mineral projects Australian investors follow. For a local reader, the useful takeaway is that CSIRO’s research and the licensing pathway keep Australian projects technically in the game, even if the visible commercial activity is happening elsewhere for now.

What the technology still cannot do, and where the next wave is heading

A calibrated view means giving the limitations the same specificity as the achievements. Bioleaching is proven, but it is not a universal solution, and three constraints in particular hold it back.

The biggest is chalcopyrite passivation. Primary copper sulfides like chalcopyrite are hard to bioleach at ambient temperatures because a passivation layer forms on the mineral surface and stalls the reaction. Since chalcopyrite hosts an enormous share of the world’s copper, this single barrier caps how much of the copper resource base bioleaching can currently reach.

Slow reaction kinetics is the second. Heap leach cycles can stretch to months or even years, which constrains throughput and ties up cash far longer than a smelter would.

Third, the microbes are sensitive. Temperature, pH, and chloride levels all affect microbial activity, which is difficult to control in large open heaps or extreme climates.

The named limitations to watch for:

• Slow reaction kinetics constraining throughput
• Chalcopyrite passivation limiting primary copper sulfide recovery
• Sensitivity to pH, temperature, and chloride
• Regulatory scrutiny where engineered or genetically modified organisms are used

The encouraging part is that the most active research threads target these problems head-on. Synthetic biology is being used to engineer microbes with better metal tolerance, faster kinetics, and greater selectivity. Extremophile research at CSIRO and the University of Cape Town is developing microbes that work at higher temperatures, aimed directly at the chalcopyrite dissolution problem. Saline-tolerant consortia are being engineered for water-constrained sites.

Where the frontier is heading:

• Synthetic biology for faster, more selective leaching
• Extremophiles and thermophiles targeting the chalcopyrite temperature barrier
• Saline tolerance for water-constrained operations
• Expanded target metals including lithium, rare earths, nickel, and cobalt
• E-waste recovery using bacteria and fungi on circuit boards

The e-waste signal Using specialised bacteria and fungi to recover gold, copper, and precious metals from electronic waste is identified as one of the fastest-growing segments in the sector, opening a metal source that never required a mine at all.

That two of the field’s most active research threads both target chalcopyrite tells you the sector has a clear priority. Solving it would materially expand the ore base bioleaching can economically reach.

Biomining battery metals sits at an earlier commercialisation stage than copper bioleaching, with lithium, cobalt, and nickel recovery from low-grade sources still largely in pilot or demonstration phases rather than the continuous heap operations that define the copper sector.

Reading the biomining landscape without the hype

The most useful thing to take from all of this is not a list of names but a filter. Biomining companies fall into four tiers, and each tier carries a different standard of proof.

Two variables tell you most about whether a claim is credible. First, which mineral is being targeted, since secondary sulfides are well within reach while primary sulfides like chalcopyrite remain the hard problem. Second, whether a deployment is operational, pilot-scale, or merely referenced in a study.

The direction of travel is clear. The market is projected to grow from USD 11 billion in 2024 to USD 27.3 billion by 2032, driven largely by demand for battery metals: copper, cobalt, nickel, and lithium. This is a landscape in active development, not a settled story.

For readers exploring how e-waste recovery compares to conventional mining on a cost-per-tonne-of-metal basis, our dedicated guide to urban mining economics examines the technical barriers and break-even conditions that determine when processing electronic scrap becomes genuinely competitive with primary extraction.

This article is for informational purposes only and should not be considered financial advice. Investors should conduct their own research and consult with financial professionals before making investment decisions.

Past performance does not guarantee future results. Financial projections and forward-looking statements are speculative and subject to market conditions, technological development, and various risk factors.